Skip to Content

CIPLA 159 (Meloxicam 15 mg)

Pill with imprint CIPLA 159 is Yellow, Round and has been identified as Meloxicam 15 mg. It is supplied by Cipla USA.

Meloxicam is used in the treatment of osteoarthritis; inflammatory conditions; fibromyalgia; rheumatoid arthritis; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for CIPLA 159

Meloxicam

Imprint:
CIPLA 159
Strength:
15 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA
National Drug Code (NDC):
69097-0159

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide